Literature DB >> 12505813

Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia.

Beng-Choon Ho1, Daniel Alicata, Julianna Ward, David J Moser, Daniel S O'Leary, Stephan Arndt, Nancy C Andreasen.   

Abstract

OBJECTIVE: Studies of patients experiencing their first episode of psychosis have demonstrated that they typically remain undiagnosed and untreated for 1-2 years. It has been postulated that prolonged untreated psychosis may have serious effects: poor response to neuroleptic medications, poor clinical outcomes, and direct neurotoxicity. This study investigated the relationships between duration of untreated initial psychosis and neurocognitive functioning and high-resolution imaging brain measurements.
METHOD: A total of 156 subjects with DSM-IV schizophrenia, schizophreniform disorder, or schizoaffective disorder were evaluated during their first episode of psychosis. Measurements included nine domains of neurocognitive functioning, volumetric measures of total brain tissue, gray and white matter, and CSF, and measures of brain surface anatomy.
RESULTS: The mean duration of untreated initial psychosis was 74.3 weeks. Correlations between neurocognitive functioning, brain volumetric measurements, and surface anatomy measurements with duration of untreated initial psychosis were weak; none reached statistical significance. When the group was divided on the basis of median duration of untreated initial psychosis, there were again no significant differences between the groups with long and short duration of untreated initial psychosis except on two measures (verbal memory and cortical sulcal depth).
CONCLUSIONS: The absence of strong correlations suggests that untreated initial psychosis has no direct toxic neural effects. These results suggest that large-scale initiatives designed to prevent neural injury through early intervention in the prepsychotic or early psychosis phase may be based on incorrect assumptions that neurotoxicity or cognitive deterioration may be avoided. Nevertheless, early treatment is justified because it reduces suffering.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12505813     DOI: 10.1176/appi.ajp.160.1.142

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  33 in total

1.  Evidence for white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Robert W McCarley; Martha E Shenton
Journal:  Curr Opin Psychiatry       Date:  2005-03       Impact factor: 4.741

2.  Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia.

Authors:  Beng-Choon Ho; Thomas H Wassink; Steven Ziebell; Nancy C Andreasen
Journal:  Schizophr Res       Date:  2011-03-21       Impact factor: 4.939

3.  Early detection of first-episode psychosis: the effect on 1-year outcome.

Authors:  Tor K Larsen; Ingrid Melle; Bjørn Auestad; Svein Friis; Ulrik Haahr; Jan Olav Johannessen; Stein Opjordsmoen; Bjørn Rishovd Rund; Erik Simonsen; Per Vaglum; Thomas McGlashan
Journal:  Schizophr Bull       Date:  2006-06-29       Impact factor: 9.306

Review 4.  [Early recognition and intervention for schizophrenia].

Authors:  N Mossaheb; G Wiesegger; G P Amminger; S Kasper; J Tauscher
Journal:  Nervenarzt       Date:  2006-01       Impact factor: 1.214

Review 5.  Schizopsychotic symptom-profiles and biomarkers: beacons in diagnostic labyrinths.

Authors:  Tomas Palomo; Richard M Kostrzewa; Richard J Beninger; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

Review 6.  [Frontal brain volume reduction due to antipsychotic drugs?].

Authors:  V Aderhold; S Weinmann; C Hägele; A Heinz
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

7.  Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.

Authors:  Beng-Choon Ho; Peter Milev; Daniel S O'Leary; Amy Librant; Nancy C Andreasen; Thomas H Wassink
Journal:  Arch Gen Psychiatry       Date:  2006-07

Review 8.  Medication-free research in early episode schizophrenia: evidence of long-term harm?

Authors:  John R Bola
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

9.  Association Between Duration of Untreated Psychosis and Frontostriatal Connectivity During Maintenance of Visuospatial Working Memory.

Authors:  Ashwinee Manivannan; William Foran; Maria Jalbrzikowski; Vishnu P Murty; Gretchen L Haas; Goda Tarcijonas; Beatriz Luna; Deepak K Sarpal
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-01-30

10.  Lack of an inverse relationship between duration of untreated psychosis and cognitive function in first episode schizophrenia.

Authors:  Terry E Goldberg; Katherine E Burdick; Joanne McCormack; Barbara Napolitano; Raman C Patel; Serge M Sevy; Robert Goldman; Todd Lencz; Anil K Malhotra; John M Kane; Delbert G Robinson
Journal:  Schizophr Res       Date:  2008-11-29       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.